Company intelligence / Profile preview

Biomedical Chitosan

Cooroy/Sunshine Coast, Queensland, AUSbiomedicalchitosan.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Biomedical Chitosan manufactures and supplies high-quality chitin and chitosan using a proprietary, environmentally friendly process that converts seafood processing waste into valuable biomaterials. Their products are currently available for research and development purposes, with future plans to obtain regulatory approval for active pharmaceutical ingredient manufacturing. The company focuses on applications such as surgical adhesives and tissue repair but does not have clinical-stage therapeutic programs at this time.

Therapeutic areas: OtherOphthalmologyNeurology
Modalities: Biomaterials
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Biomedical Chitosan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomedical Chitosan.

Explore the full profile